Account Navigation

Account Navigation

Currency - All prices are in AUD

Currency - All prices are in AUD
 Loading... Please wait...
Rescuer Medical

TMI

Aerobika OPEP device - TMI

$142.85 (inc GST) $142.85 (exc GST)

TMI

Aerobika OPEP device - TMI

$142.85 (inc GST) $142.85 (exc GST)
Weight:
0.50 KGS
Shipping:
$15.00 (Fixed shipping cost)
Quantity:

Out of Stock

Expected release date is 15th Sep 2017
Share

Product Description

Please seek medical advice to assure yourself that the Aerobika OPEP device is definitely right for you.


Aerobika*
 Oscillating Positive Expiratory Pressure Therapy System    (This Item is GST FREE)

Have you experienced a COPD exacerbation (flare-up)? Acute flare-ups are the most common reason for medical visits, hospital admissions, and deaths in patients with COPD.(1) After a COPD flare-up your lungs may be weakened putting you at risk of another. In fact, 1 in 5 patients hospitalized for a COPD flare-up require re-hospitalization within 30 days. (2)

It's time to break the COPD flare-up cycle. The drug-free Aerobika* device can help.

Using the Aerobika* device in addition to usual COPD treatment after a flare-up has been shown to reduce hospital re-admittance by 28% in the first 30 days after flare-up.(3) It is drug-free and easy-to-use with no side-effects or drug interactions.

 

In a patient satisfaction survey, 97% of respondents said they would continue to use the Aerobika* device.†4

 

 

 

 

References: 

†Patient satisfaction survey given to 504 patients after ≥3 weeks of twice-daily use of the Aerobika* device.
1 O’Donnell DE, et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease – 2007 update. Can Respir J. 2007;14(Suppl B):5B-32B.
2 Shah T, et al. COPD Readmissions: Addressing COPD in the Era of Value-Based Healthcare. Chest. 2016 May 7. doi: 10.1016/j.chest.2016.05.002. [Epub ahead of print]
3 Burudpakdee C, et al. A Real World Study of Aerobika* OPEP in Chronic Obstructive Pulmonary Disease Patients, Investigating Hospital Related Exacerbations. Manuscript.
4 Harkness H, et al. Survey of Patients Using an Oscillating Positive Expiratory Pressure Device Indicates Improvement in Well-Being and Compliance to Therapy. Presented at: Canadian Respiratory Conference. April 23–25, 2015. Ottawa, Ontario.
5 S Svenningsen et al. Presented at ERS 2014.
6 World Health Organization, Fact sheet N°310 Updated May 2014

Product Reviews

Related Products